title: Prevalence of Non-Alcoholic Fatty Liver Disease and Its Predictors in North of Iran.
abstract: BACKGROUND
  Nonalcoholic fatty liver disease (NAFLD) is one of the aspects of metabolic syndrome (MetS). Due to the increase of MetS in Iran, this study was conducted to determine the prevalence of NAFLD, its potential predictors and their sex distribution in north of Iran, Amol.
  
  
  METHODS
  In 2008 this population based cross-sectional study included 5023 adult individuals who were randomly selected from Amol healthcare centers. Blood analysis and hepatic sonography was performed for each individual and Clinical histories were reviewed. MetS was defined according to the National Cholesterol Education Program Adult Treatment Panel III. Chi-square test, univariate and multivariate logistic regression were used to analyze data.
  
  
  RESULTS
  The prevalence of NAFLD and metabolic syndrome was 43.8% and 29.6% respectively. Both NAFLD and metabolic syndrome were significantly more prevalent in women. There was a stronger association between these two factors in women which may indicate MetS has a much more potency to result in NAFLD in women. The strongest predictors of NAFLD in men were waist circumference>102 cm, serum ALT ≥40 (U/L) and the age group of 40-60 years. The strongest predictors of NAFLD in women were waist circumference>88 cm, the age groups of 40-60 and >60 years.
  
  
  CONCLUSIONS
  The observed prevalence is alarming because almost 7out of 10 subjects with MetS had NAFLD. As high waist circumference was an important predictor of NAFLD in both sexes, health care policies to reduce the incidence of obesity in the country will have an important impact on the occurrence of NAFLD.
authors.affiliation: 1. Gastrointestinal and Liver Disease Research Center (GILDRC), Iran University of Medical Sciences , Tehran, Iran.
authors.forename: Bahareh
authors.initials: B
authors.lastname: Amirkalali
authors.affiliation: 2. Digestive Disease Research Institute, Tehran University of Medical Sciences , Tehran, Iran.
authors.forename: Hossein
authors.initials: H
authors.lastname: Poustchi
authors.affiliation: 3. School of Medicine, Iran University of Medical Sciences , Tehran, Iran.
authors.forename: Hossein
authors.initials: H
authors.lastname: Keyvani
authors.affiliation: 1. Gastrointestinal and Liver Disease Research Center (GILDRC), Iran University of Medical Sciences , Tehran, Iran.
authors.forename: Mahmood Reza
authors.initials: MR
authors.lastname: Khansari
authors.affiliation: 1. Gastrointestinal and Liver Disease Research Center (GILDRC), Iran University of Medical Sciences , Tehran, Iran.
authors.forename: Hossein
authors.initials: H
authors.lastname: Ajdarkosh
authors.affiliation: 1. Gastrointestinal and Liver Disease Research Center (GILDRC), Iran University of Medical Sciences , Tehran, Iran.
authors.forename: Mansooreh
authors.initials: M
authors.lastname: Maadi
authors.affiliation: 1. Gastrointestinal and Liver Disease Research Center (GILDRC), Iran University of Medical Sciences , Tehran, Iran.
authors.forename: Masoud Reza
authors.initials: MR
authors.lastname: Sohrabi
authors.affiliation: 1. Gastrointestinal and Liver Disease Research Center (GILDRC), Iran University of Medical Sciences , Tehran, Iran.
authors.forename: Farhad
authors.initials: F
authors.lastname: Zamani
keywords: Metabolic syndrome; Non-Alcoholic fatty liver disease (NAFLD); Risk factors